ArticleNature communications2026

A chromatin-informed transcriptional regulatory framework to stratify patients and guide therapy selection in triple-negative breast cancer.

Shalini Bahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.